Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAMELA M SANTAMARIA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1083693287
CMS profile
3994
Location
OMAHA, NE

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$4,338.32

331 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,210.32 328
Education $128.00 3

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
AbbVie Inc. $589.51 43
Teva Pharmaceuticals USA, Inc. $444.21 38
Novartis Pharmaceuticals Corporation $194.85 20
Genentech USA, Inc. $175.95 15
Lilly USA, LLC $172.16 12
IMPEL PHARMACEUTICALS INC. $169.68 19
Neurocrine Biosciences, Inc. $158.66 20
Biogen, Inc. $155.22 21
Celgene Corporation $152.99 19
Axsome Therapeutics, Inc. $140.55 9
ANI Pharmaceuticals, Inc. $137.80 9
UCB, Inc. $131.70 14
GENZYME CORPORATION $131.44 5
Amneal Pharmaceuticals LLC $130.60 10
ACADIA Pharmaceuticals Inc $129.79 9
Mallinckrodt Hospital Products Inc. $115.27 4
JAZZ PHARMACEUTICALS INC. $97.37 5
Sumitomo Pharma America, Inc. $95.12 10
BANNER LIFE SCIENCES, LLC $77.08 3
Kyowa Kirin, Inc. $75.40 4
MDD US Operations, LLC $69.90 4
Ipsen Biopharmaceuticals, Inc $65.13 3
EMD Serono, Inc. $64.28 3
IDORSIA PHARMACEUTICALS US INC $55.26 3
CSL Behring $44.57 2
Takeda Pharmaceuticals U.S.A., Inc. $44.16 2
SK Life Science, Inc. $43.35 2
PFIZER INC. $38.94 2
Bio Products Laboratory USA, Inc. $37.97 2
Otsuka America Pharmaceutical, Inc. $34.50 2
Lundbeck LLC $32.21 2
ARGENX US, INC. $31.02 1
Merck Sharp & Dohme LLC $30.78 2
Merz Pharmaceuticals, LLC $29.20 1
Janssen Pharmaceuticals, Inc $27.04 1
Amgen Inc. $25.23 1
Grifols USA, LLC $24.17 1
Octapharma USA, Inc. $23.59 1
Boston Scientific Corporation $23.42 1
Neurelis, Inc. $23.40 1
MITSUBISHI TANABE PHARMA AMERICA, INC. $22.44 1
Alnylam Pharmaceuticals Inc. $22.26 1
Eisai Inc. $19.28 1
Alexion Pharmaceuticals, Inc. $15.98 1
Scilex Pharmaceuticals Inc. $14.89 1

Page 6 of 7; records 251–300 of 331 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAMELA M SANTAMARIA

NPI 1083693287 · CMS profile ID 3994

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

OMAHA, NE

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 7; records 251–300 of 331 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083693287?year=2023&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAMELA M SANTAMARIA, NPI 1083693287, CMS profile ID 3994. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 331 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083693287?year=2023&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). PAMELA M SANTAMARIA, NPI 1083693287, CMS profile ID 3994. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 7; records 251–300 of 331 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083693287?year=2023&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
PAMELA M SANTAMARIA, NPI 1083693287, CMS profile ID 3994, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 7; records 251–300 of 331 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1083693287?year=2023&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

331 matching records · $4,338.32 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 331 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–300 of 331.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Mallinckrodt Hospital Products Inc. $39.5904/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042886307 CMS
Neurocrine Biosciences, Inc. $4.1604/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052146669 CMS
Genentech USA, Inc. $1.5304/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040496995 CMS
Genentech USA, Inc. $15.3404/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040497093 CMS
AbbVie Inc. $19.9103/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998820187 CMS
Sumitomo Pharma America, Inc. $4.2203/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030776261 CMS
ANI Pharmaceuticals, Inc. $1.2003/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034121161 CMS
ANI Pharmaceuticals, Inc. $13.1803/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034158499 CMS
Genentech USA, Inc. $11.6103/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040497027 CMS
IMPEL PHARMACEUTICALS INC. $1.6403/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989365233 CMS
IMPEL PHARMACEUTICALS INC. $14.1903/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989365239 CMS
Alnylam Pharmaceuticals Inc. $22.2603/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006132207 CMS
IMPEL PHARMACEUTICALS INC. $6.4303/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989365227 CMS
Axsome Therapeutics, Inc. $18.3103/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056199283 CMS
Teva Pharmaceuticals USA, Inc. $10.1603/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056719697 CMS
IMPEL PHARMACEUTICALS INC. $16.4303/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989365223 CMS
AbbVie Inc. $23.5903/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998820183 CMS
Genentech USA, Inc. $8.3203/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040496979 CMS
AbbVie Inc. $6.3003/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998820179 CMS
Lilly USA, LLC $18.3503/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032072567 CMS
ANI Pharmaceuticals, Inc. $27.7003/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034111699 CMS
ANI Pharmaceuticals, Inc. $0.9103/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034159467 CMS
Celgene Corporation $2.7303/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016375563 CMS
Celgene Corporation $2.7203/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016375569 CMS
MDD US Operations, LLC $20.8503/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052893643 CMS
Teva Pharmaceuticals USA, Inc. $10.1603/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056719685 CMS
Genentech USA, Inc. $24.4003/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040497051 CMS
Sumitomo Pharma America, Inc. $15.7503/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030776249 CMS
Neurocrine Biosciences, Inc. $8.8803/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052146663 CMS
Genentech USA, Inc. $11.7502/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040497021 CMS
Celgene Corporation $6.7002/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016375551 CMS
Celgene Corporation $1.2102/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016375559 CMS
GENZYME CORPORATION $25.0002/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049885215 CMS
Neurocrine Biosciences, Inc. $6.7602/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052146657 CMS
AbbVie Inc. $25.3302/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998820175 CMS
IMPEL PHARMACEUTICALS INC. $3.5402/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989365213 CMS
IMPEL PHARMACEUTICALS INC. $3.3802/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989365219 CMS
MDD US Operations, LLC $14.7902/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052893635 CMS
IMPEL PHARMACEUTICALS INC. $2.0602/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989365207 CMS
Sumitomo Pharma America, Inc. $3.2902/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030776265 CMS
Genentech USA, Inc. $16.3802/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040496987 CMS
MDD US Operations, LLC $13.9402/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052893633 CMS
Neurocrine Biosciences, Inc. $2.1502/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052146645 CMS
Neurocrine Biosciences, Inc. $16.5702/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052146651 CMS
UCB, Inc. $3.5102/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021377063 CMS
UCB, Inc. $23.3302/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021377127 CMS
Mallinckrodt Hospital Products Inc. $17.2402/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042886301 CMS
Kyowa Kirin, Inc. $19.2702/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027015951 CMS
CSL Behring $23.8802/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043011829 CMS
Genentech USA, Inc. $7.5602/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040497067 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $19,413.57 385
PY2020 $13,171.59 275
PY2021 $27,863.09 387
PY2022 $5,708.87 353
PY2023 $4,338.32 331
PY2024 $12,938.78 315
PY2025 $6,450.09 327

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $8,600.00 7
PY2021 Principal investigator $2,000.00 1
PY2020 Recipient $6,500.00 2
PY2019 Recipient $6,000.00 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 TG Therapeutics, Inc. $800.00 11/30/2025 Non-covered Recipient Entity
Neurology Consultants of Nebraska
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200423
Principal investigator 1 TG Therapeutics, Inc. $200.00 11/01/2025 Non-covered Recipient Entity
Neurology Consultants of Nebraska
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200421
Principal investigator 1 TG Therapeutics, Inc. $400.00 09/30/2025 Non-covered Recipient Entity
Neurology Consultants of Nebraska
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200377
Principal investigator 1 TG Therapeutics, Inc. $3,700.00 07/31/2025 Non-covered Recipient Entity
Neurology Consultants of Nebraska
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200375
Principal investigator 1 TG Therapeutics, Inc. $200.00 06/01/2025 Non-covered Recipient Entity
Neurology Consultants of Nebraska
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200373
Principal investigator 1 TG Therapeutics, Inc. $3,200.00 03/31/2025 Non-covered Recipient Entity
Neurology Consultants of Nebraska
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200371
Principal investigator 1 TG Therapeutics, Inc. $100.00 03/01/2025 Non-covered Recipient Entity
Neurology Consultants of Nebraska
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200369